Category: Faculty
Rezk Honored With Two Prestigious Awards
October 9, 2006Naser Rezk, a research associate in the Clinical Pharmacology and Analytical Chemistry Laboratory at the School of Pharmacy, has been honored with two prestigious awards: the Chancellor’s Award for Excellence in Innovation and the State Employees’ Award for Excellence in Innovation. Rezk is responsible for developing ways to measure drugs and metabolites in biological fluids to answer important questions in the treatment of HIV/AIDS and other diseases. The data he generates are critical to improving patient care. The awards were given in recognition of Rezk’s work in establishing the Clinical Pharmacology and Analytical Chemistry Laboratory’s top ranking in the number of drugs measured and the … Read more
Faculty Mentoring Program Launched with $1 Million Endowment
September 21, 2006The UNC School of Pharmacy has created a new faculty mentoring program—believed to be the first of its kind among the nation’s pharmacy schools—designed to help young faculty succeed by matching them up with experienced mentors both inside and outside the University. The Bill and Karen Campbell Faculty Mentoring Program is supported by revenue generated from the $1 million Bill and Karen Campbell Professorship, which covers mentoring expenses and provides honoraria for the mentors. Supporters of the School and friends of the Campbells created the professorship through the Pharmacy Foundation of North Carolina, Inc. to honor the couple’s long commitment … Read more
Brouwer Honored by the University of Kentucky
September 1, 2006Kim Brouwer, chair of the Division of Pharmacotherapy and Experimental Therapeutics, has been selected as the inaugural recipient of the University of Kentucky Outstanding Graduate Program Alumni for the Pharmaceutical Sciences. The goal of this award is to honor graduates of the University of Kentucky in recognition of their accomplishments and contributions to scholarship, education, and research in the pharmaceutical sciences.
Jian Liu Promoted to Associate Professor
August 8, 2006Jian Liu, PhD, who joined the Division of Medicinal Chemistry and Natural Products in 2000, has been promoted to associate professor with tenure. Liu’s research interests are centered in glycobiology, an area of science that holds tremendous significance for medicinal chemistry and drug discovery. Liu and his group’s work on the synthesis of polysaccharides has recently led to the successful production of a synthetic form of heparin. Liu believes that the chemical synthesis of polysaccharides will play a significant role in drug development in the future, particularly in the treatment of herpes, cancer, and bacterial infection, and he hopes his method will accelerate … Read more
McLeod Joins School as Eshelman Professor
July 19, 2006Howard McLeod, PharmD, formerly of Washington University in St. Louis, has been appointed the Fred Eshelman Distinguished Professor in the Division of Pharmacotherapy and Experimental Therapeutics at the UNC School of Pharmacy. He is also the director of the new UNC Institute for Pharmacogenomics and Individualized Therapy and a member of the UNC Lineberger Comprehensive Cancer Center. “Dr. McLeod is one of the pioneers in the field of cancer pharmacogenomics and we are extremely pleased that he has decided to join the faculty,” said Kim Brouwer, PharmD, chair of the division. Richard Goldberg, MD, associate director of UNC Lineberger, said, … Read more
Farrington Elected to PPAG Board
July 17, 2006Elizabeth Farrington, clincial assistant professor, has been elected to the Pediatric Pharmacy Advocacy Group’s Board of Directors. The Pediatric Pharmacy Advocacy Group is an international, non-profit, volunteer organization of healthcare providers dedicated to improving the lives of children.The sole purpose of PPAG is to advocate safe and effective medication use in children through communication, education, and research.
Kashuba Awarded $1.7 Million to Study Drug-Interaction Potential of New HIV Protease Inhibitor
June 19, 2006Angela D. M. Kashuba, PharmD, has been awarded a $1.7 million contract from Boehringer Ingelheim to study the drug-interaction potential of tipranavir, a new HIV protease inhibitor. Protease is an enzyme that HIV needs in order to make new viruses. When protease is blocked, HIV makes copies of itself that can’t infect new cells. According to Kashuba, many individual drug-drug interaction studies have demonstrated tipranavir’s high interaction potential. Kashuba’s novel phenotyping approach will help in understanding the basis for these interactions and will form the groundwork for further exploration of potentially important drug interactions. The title of Kashuba’s project is “Evaluating the Effects of Tipranavir (with Ritonavir) … Read more
Hansen Receives NIH Career Development Award
June 14, 2006Richard Hansen, PhD, was named a Clinical Research Scholar under the UNC Multidisciplinary Clinical Research Career Development Program. This award is part of the National Institutes of Health Roadmap Initiative and will provide salary and research funding over five years to support Hansen’s work in the multidisciplinary management of depression in primary care. Hansen’s project “The Quality of Antidepressant Use in Primary Care” focuses on understanding and improving adherence to antidepressants in non-psychiatric settings. The UNC MCRCDP is designed to re-engineer the clinical research enterprise by training new clinical research leaders, which is a key component of the NIH Roadmap. Eugene … Read more
Kohn Awarded $1.3 Million to Study Treatment of Neurological Disorders
June 14, 2006Harold Kohn, PhD, Kenan Professor in the UNC School of Pharmacy’s Division of Medicinal Chemistry and Natural Products, has been awarded a $1.3 million grant from the National Institute of Neurological Disorders and Stroke. The title of Kohn’s project is “Novel Methods to Identify Targets of the Neurological Agent (R)-Lacosamide.” The NIH-funded study is a joint project between the Kohn and Rihe Liu Laboratories. Liu is an assistant professor at the School. According to Kohn’s proposal, epilepsy and neuropathic pain are major neurological disorders that can be treated with a number of different seizure medications. “Even with the use of these medications, many … Read more
Xiao Appointed Fred Eshelman Distinguished Professor of Gene Therapy
June 12, 2006Xiao Xiao, PhD, has been appointed Fred Eshelman Distinguished Professor of Gene Therapy in the Division of Molecular Therapeutics in the UNC School of Pharmacy. Before coming to the School, Xiao was an associate professor at the University of Pittsburgh School of Medicine where he held several joint appointments. He was also an adjunct professor at Huazhong Science and Technology University Tongji Medical College in Wuhan, China, and a guest professor at Fudan University Shanghai Medical College in Shanghai, China. In 1982 Xiao received a BS in pharmaceutical chemistry from the Shanghai Medical University School of Pharmacy. He received a MS … Read more